Cardax CDXI Stock
Cardax Price Chart
Cardax CDXI Financial and Trading Overview
| Cardax stock price | 0.0000 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0011 USD |
| Volume | 1K USD |
| Avg. Volume | 0 USD |
| Market Cap | 4 USD |
| Beta (5Y Monthly) | 0.226 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.29 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CDXI Valuation Measures
| Enterprise Value | 5.33M USD |
| Trailing P/E | N/A |
| Forward P/E | -2.0E-5 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.988704E-6 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 10.652 |
| Enterprise Value/EBITDA | -1.843 |
Trading Information
Cardax Stock Price History
| Beta (5Y Monthly) | 0.226 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 0.0011 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0002 USD |
| 200-Day Moving Average | 0.0003125 USD |
CDXI Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 802.52K |
| Float | 590.2K |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:200 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2020 |
| Most Recent Quarter (mrq) | March 31, 2021 |
| Next Fiscal Year End | December 31, 2021 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -737.57% |
| Gross Margin | 65.74% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -112.55% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 500.71K USD |
| Revenue Per Share (ttm) | 0.62 USD |
| Quarterly Revenue Growth (yoy) | -26.80% |
| Gross Profit (ttm) | 342.82K USD |
| EBITDA | -2893813 USD |
| Net Income Avi to Common (ttm) | -5434757 USD |
| Diluted EPS (ttm) | -1.29 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 61.71K USD |
| Total Cash Per Share (mrq) | 0.08 USD |
| Total Debt (mrq) | 5.4M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.087 |
| Book Value Per Share (mrq) | -14.146 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1559849 USD |
| Levered Free Cash Flow (ttm) | 349.14K USD |
Profile of Cardax
| Country | United States |
| State | HI |
| City | Honolulu |
| Address | 2800 Woodlawn Drive |
| ZIP | 96822 |
| Phone | 808 457 1400 |
| Website | https://www.cardaxpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia; and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax, Inc. is based in Honolulu, Hawaii.
Q&A For Cardax Stock
What is a current CDXI stock price?
Cardax CDXI stock price today per share is 0.0000 USD.
How to purchase Cardax stock?
You can buy CDXI shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cardax?
The stock symbol or ticker of Cardax is CDXI.
Which industry does the Cardax company belong to?
The Cardax industry is Biotechnology.
How many shares does Cardax have in circulation?
The max supply of Cardax shares is 0.
What is Cardax Price to Earnings Ratio (PE Ratio)?
Cardax PE Ratio is now.
What was Cardax earnings per share over the trailing 12 months (TTM)?
Cardax EPS is -1.29 USD over the trailing 12 months.
Which sector does the Cardax company belong to?
The Cardax sector is Healthcare.